Tekmira Pharmaceuticals Corporation (TKMR) Stock Benefits From Ebola Crisis

Should investors consider a speculative bet in Ebola treatments?

In an article titled “The Free Market Won’t Produce an Ebola Cure,” Forbes contributor Tim Worstall argues the market for Ebola cures is significantly low, and thus a free market cure to the medical crisis grounded in poor West African nations isn’t likely to gain traction.

But what if the disease spreads into more wealthy nations? What if the deadly virus suddenly gets legs throughout the world?

Tekmira Pharmaceuticals benefiting from Ebola crisis

Benefiting from such a terrible situation would be Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), which recently received news the US Federal Drug Administration modified the clinical hold on Tekmira’s...